{
    "code": "10000581",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000581",
    "time": "2017-12-13 03:26:01",
    "許可證字號": "衛署菌疫輸字第000581號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/01\/11",
    "發證日期": "89\/01\/11",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000058106",
    "中文品名": "〝瑞士〞宜保利血注射液２０００單位\/毫升",
    "英文品名": "EPREX INJECTION 2000IU\/ML",
    "適應症": "治療與慢性腎臟功能失調有關的貧血症狀或因此而需要輸血之患者、治療與癌症化學治療有關的症狀性貧血。",
    "劑型": "270注射劑",
    "包裝": "0.5ml(1000IU)注射針筒，含針頭防刺\/護裝置 ( Passive Needle Guard ) 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "EPOETINALFA"
    ],
    "限制項目": "02輸　入 1D須執行風險管理計畫",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F430263000  CILAG AG",
        "製造廠廠址": "HOCHSTRASSE 201, CH-8200 SCHAFFHAUSEN, SWITZERLAND",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049020007 血液代用品與血漿代用品及基因重組製劑Substitutes of blood, substitutes of plasma and preparationsof gennetic recombinants",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1600001200",
            "成分名稱": "EPOETIN ALFA",
            "含量描述": "",
            "含量": "16.8000000000",
            "單位": "MCG"
        }
    ],
    "仿單外盒": [
        {
            "title": "[打樣版] PI_Eprex_CCDS 14Apr2017_v1702_1011-106-11-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000581&Seq=019&Type=9"
        },
        {
            "title": "Eprex 2000 IU外盒-104-09-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000581&Seq=001&Type=8"
        }
    ]
}